ARIBIOLAB (261780) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, ARIBIOLAB (261780) reported revenue of 159 million KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
2025159 million KRW-14.3 billion KRW-16.0 billion KRW[source]
2024371 million KRW-7.7 billion KRW-10.1 billion KRW[source]
2023294 million KRW-6.4 billion KRW-1.7 billion KRW[source]
2022179 million KRW-6.5 billion KRW-6.7 billion KRW[source]
2021500 million KRW-6.1 billion KRW-18.4 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
202529.8 billion KRW17.9 billion KRW11.9 billion KRW[source]
202447.2 billion KRW19.5 billion KRW27.7 billion KRW[source]
202345.1 billion KRW9.7 billion KRW35.4 billion KRW[source]
202261.1 billion KRW27.7 billion KRW33.4 billion KRW[source]
202165.3 billion KRW25.7 billion KRW39.6 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice